Tarsus Pharmaceuticals, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
ABOS
Acumen Pharmaceuticals, Inc. |
$1.70 | $157.41 M | -2.5 | 51 | $0 |
ALDX
Aldeyra Therapeutics, Inc. |
$5.11 | $229.34 M | -7.57 | 9 | $0 |
CNTA
Centessa Pharmaceuticals plc |
$16.49 | $884.24 M | -6.2 | 76 | $6.85 M |
CNTB
Connect Biopharma Holdings Limited |
$0.97 | $108.00 M | -1.81 | 81 | $0 |
DSGN
Design Therapeutics, Inc. |
$5.14 | $217.51 M | -3.7 | 54 | $0 |
ELDN
Eledon Pharmaceuticals, Inc. |
$4.42 | $107.05 M | -2.26 | 20 | $0 |
ETON
Eton Pharmaceuticals, Inc. |
$16.87 | $92.74 M | 120.33 | 30 | $31.64 M |
GLUE
Monte Rosa Therapeutics, Inc. |
$5.51 | $243.38 M | -1.59 | 133 | $0 |
GNFT
Genfit S.A. |
$3.61 | $269.95 M | -8.62 | 169 | $28.57 M |
HOWL
Werewolf Therapeutics, Inc. |
$1.44 | $151.66 M | -3.17 | 45 | $19.94 M |
IKNA
Ikena Oncology, Inc. |
$1.48 | $84.45 M | -1.11 | 14 | $9.16 M |
LIAN
LianBio |
$0.32 | $34.47 M | -0.39 | 163 | $0 |
NUVB
Nuvation Bio Inc. |
$2.56 | $684.66 M | -8.66 | 203 | $0 |
NUVL
Nuvalent, Inc. |
$82.09 | $5.11 B | -32.72 | 127 | $0 |
OPT
Opthea Limited |
$4.88 | $214.34 M | -1.04 | 33 | $124,666 |
PEPG
PepGen Inc. |
$1.96 | $537.15 M | -5.11 | 76 | $0 |
PHVS
Pharvaris N.V. |
$18.90 | $843.31 M | -5.8 | 83 | $0 |
RLYB
Rallybio Corporation |
$0.87 | $61.34 M | -0.79 | 43 | $0 |
STOK
Stoke Therapeutics, Inc. |
$10.70 | $774.50 M | -6.14 | 110 | $8.78 M |
TRDA
Entrada Therapeutics, Inc. |
$12.74 | $531.37 M | 22.81 | 177 | $129.01 M |
TVTX
Travere Therapeutics, Inc. |
$20.72 | $542.80 M | -1.32 | 380 | $145.24 M |
TYRA
Tyra Biosciences, Inc. |
$16.01 | $1.04 B | -11.7 | 49 | $0 |